TriSalus Life Sciences Inc.

TLSI | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.93

-$0.05 (-1.00%)

Sep 22, 2026, 12:35 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-39.23M	-30.05M	-59.36M	-47.19M	-28.85M	-711.39K
Depreciation & Amortization	626K	744K	684K	398K	464K	n/a
Stock-Based Compensation	9.13M	5.44M	1.4M	368K	109K	n/a
Other Working Capital	711K	-1.94M	751K	-2.57M	-1.84M	-569.98K
Other Non-Cash Items	9.39M	-7.43M	6.16M	11.81M	5.71M	603.77K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	2.07M	-9.55M	537K	2.3M	-131K	-569.98K
Operating Cash Flow	-18.01M	-40.84M	-50.58M	-32.31M	-22.7M	-677.6K
Capital Expenditures	-918K	-345K	-588K	-786K	-1.26M	-1
Cash Acquisitions	80K	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	-250M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-1M	-1.13M	-1.16M	n/a
Investing Cash Flow	-838K	-345K	-1.59M	-1.79M	-2.26M	-250M
Debt Repayment	9.92M	24.92M	-87K	-131K	-1.3M	-178.08K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-2.07M	-2.52M	45.53M	94K	54K	n/a
Financial Cash Flow	30.76M	37.94M	54.63M	13.46M	50.77M	252.01M
Net Cash Flow	11.91M	-3.25M	2.46M	-20.64M	25.81M	1.33M
Free Cash Flow	-18.93M	-41.19M	-51.17M	-33.1M	-23.96M	-677.6K
Adj. Free Cash Flow	-28.06M	-46.63M	-52.57M	-33.47M	-24.06M	-677.6K
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	-918K	-345K	-588K	-786K	-1.26M	-1
Owner Earnings	-18.01M	-40.84M	-50.58M	-32.31M	-22.7M	-677.6K